New Regimen of Combining Hepatic Arterial Infusion Chemotherapy and Lipiodol Embolization in Treating Hepatocellular Carcinoma with Main Portal Vein Invasion.

MLA

Li, Ming-Feng, et al. “New Regimen of Combining Hepatic Arterial Infusion Chemotherapy and Lipiodol Embolization in Treating Hepatocellular Carcinoma with Main Portal Vein Invasion.” Journal of Personalized Medicine, vol. 13, no. 1, Jan. 2023, p. 88. EBSCOhost, https://doi.org/10.3390/jpm13010088.

APA

Li, M.-F., Liang, H.-L., Chiang, C.-L., Tsai, W.-L., Chen, W.-C., Tsai, C.-C., & Chen, I.-S. (2023). New Regimen of Combining Hepatic Arterial Infusion Chemotherapy and Lipiodol Embolization in Treating Hepatocellular Carcinoma with Main Portal Vein Invasion. Journal of Personalized Medicine, 13(1), 88. https://doi.org/10.3390/jpm13010088

Chicago

Li, Ming-Feng, Huei-Lung Liang, Chia-Ling Chiang, Wei-Lun Tsai, Wen-Chi Chen, Cheng-Chung Tsai, and I-Shu Chen. 2023. “New Regimen of Combining Hepatic Arterial Infusion Chemotherapy and Lipiodol Embolization in Treating Hepatocellular Carcinoma with Main Portal Vein Invasion.” Journal of Personalized Medicine 13 (1): 88. doi:10.3390/jpm13010088.